See All Slides - tctmd.com

Slides

Presentation TCT 2013

Case #2: A Complex Bifurcation: Dedicated Stent, Planned 2 Stents or Provisional Stent strategy?

Presenter: Gregory Pavlides

October 28, 2013

Presentation TCT 2013

Update: The Lutter Valve

Presenter: Georg Lutter

October 28, 2013

Presentation TCT 2013

An Overview of New Adjunctive Imaging Systems for TAVR

Presenter: Nicolo Piazza

October 28, 2013

Presentation TCT 2013

The SAMMPRIS Trial: Implications for Cerebral and Carotid Trial Design and Patient Management

Presenter: Leo Nelson Hopkins

October 28, 2013

Presentation TCT 2013

Renal Denervation: Ready for Primetime?

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

TCT-128. Transcatheter Implantation of Self-Expandable Vena Cava Valves for Treatment of Tricuspid Regurgitation: First-Human-Case Description

Presenter: Hans Figulla

October 28, 2013

Presentation TCT 2013

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

Presenter: Young-Hak Kim

October 28, 2013

Presentation TCT 2013

Keynote Address:
Interventional Innovation "Then and Now:" The Evolution of Translational Science, Clinical Evidence-Based Medicine, and Socioeconomic Considerations

Presenter: Elazer Edelman

October 28, 2013

Presentation TCT 2013

Close Surveillance Is Appropriate in Most!

Presenter: Jeffrey Borer

October 28, 2013

Presentation TCT 2013

TCT-129. Percutaneous Transfemoral Management of Severe Secondary Tricuspid Regurgitation with Edwards Sapien XT Bioprosthesis in Patients with Severe Heart Failure: First in Ma...

Presenter: Michael Laule

October 28, 2013

Advertisement

Slides

Case #2: A Complex Bifurcation: Dedicated Stent, Planned 2 Stents or Provisional Stent strategy?

Update: The Lutter Valve

An Overview of New Adjunctive Imaging Systems for TAVR

The SAMMPRIS Trial: Implications for Cerebral and Carotid Trial Design and Patient Management

Renal Denervation: Ready for Primetime?

TCT-128. Transcatheter Implantation of Self-Expandable Vena Cava Valves for Treatment of Tricuspid Regurgitation: First-Human-Case Description

Everolimus-eluting Stents in Left Main Disease: Precombat II 3 Year Results

Keynote Address:
Interventional Innovation "Then and Now:" The Evolution of Translational Science, Clinical Evidence-Based Medicine, and Socioeconomic Considerations

Close Surveillance Is Appropriate in Most!

TCT-129. Percutaneous Transfemoral Management of Severe Secondary Tricuspid Regurgitation with Edwards Sapien XT Bioprosthesis in Patients with Severe Heart Failure: First in Ma...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content